Fortress Biotech (FBIO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov15

Fortress Biotech released FY2025 9 Months Earnings on November 14 After-Market EST, actual revenue USD 47.18 M, actual EPS USD 0.0792

00:00

Fortress Biotech released FY2025 Q3 earnings on November 14 After-Market EST, actual revenue USD 17.63 M (forecast USD 21.02 M), actual EPS USD 0.11 (forecast USD -0.625)

00:00

Nov14

Fortress Biotech Reports Significant Improvements in Q3 2025 10-Q

13:57

Nov5

Fortress Biotech to Release FY2025 Q3 Earnings on November 12 After-Market EST, Forecast Revenue USD 21.02 M, EPS USD -0.625

00:07

Oct21

Fortress Biotech Subsidiary Urica Therapeutics Announces Initiation of Phase 3 Clinical Trials for dotinurad

12:31

Aug14

Fortress Biotech released FY2025 Semi-Annual Earnings on August 14 After-Market (EST), Actual Revenue USD 29.55 M, Actual EPS USD 0.02

23:00

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 17.63 M, Net Income 3.675 M, EPS 0.11

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 16.41 M, Net Income 13.36 M, EPS 0.45

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 13.14 M, Net Income -12.72 M, EPS -0.4807

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More